Quick Heal Technologies Ltd
Quick Heal Technologies is engaged in the business of providing security software products. The Company caters to both domestic and international market.
- Market Cap ₹ 977 Cr.
- Current Price ₹ 180
- High / Low ₹ 417 / 125
- Stock P/E
- Book Value ₹ 80.6
- Dividend Yield 0.00 %
- ROCE -4.54 %
- ROE -2.37 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Company has low interest coverage ratio.
- The company has delivered a poor sales growth of -4.78% over past five years.
- Company has a low return on equity of 1.16% over last 3 years.
- Company has high debtors of 196 days.
- Company's cost of borrowing seems high
- Working capital days have increased from 190 days to 347 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Information Technology Information Technology IT - Software Software Products
Part of BSE Information Technology BSE 1000
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 284 | 298 | 299 | 316 | 313 | 283 | 334 | 342 | 278 | 292 | 280 | 261 | |
| 190 | 192 | 202 | 192 | 183 | 190 | 192 | 236 | 275 | 274 | 286 | 290 | |
| Operating Profit | 94 | 107 | 97 | 124 | 129 | 93 | 141 | 106 | 3 | 17 | -6 | -29 |
| OPM % | 33% | 36% | 33% | 39% | 41% | 33% | 42% | 31% | 1% | 6% | -2% | -11% |
| 8 | 9 | 23 | 22 | 23 | 29 | 24 | 15 | 22 | 21 | 21 | 23 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 20 | 24 | 31 | 27 | 24 | 22 | 19 | 17 | 16 | 13 | 13 | 14 |
| Profit before tax | 82 | 93 | 90 | 119 | 129 | 100 | 146 | 104 | 9 | 26 | 2 | -20 |
| Tax % | 32% | 33% | 34% | 34% | 35% | 27% | 27% | 24% | 17% | 8% | -264% | -48% |
| 56 | 62 | 59 | 79 | 84 | 74 | 107 | 78 | 8 | 24 | 6 | -10 | |
| EPS in Rs | 9.22 | 8.91 | 8.44 | 11.21 | 11.90 | 11.47 | 16.63 | 13.48 | 1.45 | 4.50 | 1.03 | -1.92 |
| Dividend Payout % | 81% | 28% | 30% | 27% | 17% | 35% | 24% | 33% | 172% | 67% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | -1% |
| 5 Years: | -5% |
| 3 Years: | -2% |
| TTM: | -7% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | -418% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | -5% |
| 3 Years: | 4% |
| 1 Year: | -51% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 4% |
| 3 Years: | 1% |
| Last Year: | -2% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 61 | 70 | 70 | 70 | 71 | 64 | 64 | 58 | 53 | 54 | 54 | 54 |
| Reserves | 277 | 570 | 609 | 667 | 724 | 584 | 692 | 569 | 367 | 383 | 388 | 383 |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 96 | 87 | 71 | 57 | 62 | 52 | 75 | 89 | 73 | 76 | 84 | 112 | |
| Total Liabilities | 434 | 727 | 751 | 794 | 857 | 700 | 831 | 716 | 493 | 513 | 526 | 549 |
| 111 | 142 | 185 | 173 | 165 | 158 | 146 | 137 | 124 | 117 | 119 | 122 | |
| CWIP | 74 | 55 | 14 | 14 | 11 | 3 | 2 | 0 | 0 | 3 | 0 | 0 |
| Investments | 139 | 128 | 211 | 325 | 401 | 320 | 428 | 321 | 198 | 191 | 180 | 214 |
| 110 | 403 | 341 | 282 | 281 | 218 | 255 | 258 | 170 | 202 | 226 | 213 | |
| Total Assets | 434 | 727 | 751 | 794 | 857 | 700 | 831 | 716 | 493 | 513 | 526 | 549 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 78 | 81 | 50 | 96 | 63 | 71 | 100 | 78 | 31 | 18 | -25 | 18 | |
| -57 | -167 | -90 | -119 | -39 | 146 | -94 | 130 | 188 | 6 | 16 | -26 | |
| -18 | 189 | -20 | -19 | -24 | -221 | 0 | -214 | -212 | 2 | -10 | 3 | |
| Net Cash Flow | 3 | 104 | -61 | -42 | -0 | -4 | 6 | -6 | 6 | 26 | -19 | -5 |
| Free Cash Flow | 12 | 45 | 16 | 82 | 55 | 60 | 91 | 77 | 32 | 12 | -39 | 9 |
| CFO/OP | 114% | 91% | 82% | 98% | 91% | 112% | 92% | 104% | 1,390% | 106% | 402% | -90% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 87 | 118 | 116 | 119 | 146 | 146 | 164 | 185 | 161 | 165 | 222 | 196 |
| Inventory Days | 173 | |||||||||||
| Days Payable | 919 | |||||||||||
| Cash Conversion Cycle | -659 | 118 | 116 | 119 | 146 | 146 | 164 | 185 | 161 | 165 | 222 | 196 |
| Working Capital Days | -20 | 34 | 46 | 69 | 92 | 96 | 97 | 102 | 84 | 88 | 134 | 347 |
| ROCE % | 24% | 19% | 14% | 18% | 18% | 14% | 20% | 15% | 0% | 6% | -0% | -5% |
Insights
In beta| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Headcount Number |
|
|||||||||||
| Enterprise vs Consumer Revenue Mix (Enterprise %) % |
||||||||||||
| R&D Spend as % of Net Revenue % |
||||||||||||
| Active Device Endpoints / Active Licenses Million |
||||||||||||
| Channel Partners / Retail Network Number |
||||||||||||
| Distributors Number |
||||||||||||
| Number of Patents Held Number |
||||||||||||
| Total Enterprise Customers Number |
||||||||||||
| Retail/Consumer Market Share in India % |
||||||||||||
| R&D Expenditure (Percentage of Turnover) % |
||||||||||||
Extracted by Screener AI
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
29 May - Allotment of 500 Equity Shares under ESOP Scheme 2021
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
28 May - Quick Heal published transcript of Q4 and FY26 investor/analyst call held May 22, 2026.
-
Compliances-Reg.24(A)-Annual Secretarial Compliance
27 May - FY2026 secretarial compliance report notes full compliance and no non-compliances.
- Announcement under Regulation 30 (LODR)-Newspaper Publication 23 May
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
23 May - Investor/analyst call recording for Q4 and FY2026 results held on May 22, 2026 is now available online.
Annual reports
Concalls
-
May 2026TranscriptAI SummaryPPT
-
Jan 2026TranscriptAI SummaryPPT
-
Oct 2025Transcript PPT REC
-
Aug 2025Transcript PPT REC
-
May 2025TranscriptPPT REC
-
Feb 2025Transcript PPT REC
-
Oct 2024Transcript PPT REC
-
Aug 2024Transcript PPT REC
-
May 2024Transcript PPT REC
-
Jan 2024Transcript PPT
-
Oct 2023Transcript PPT
-
Jul 2023TranscriptAI SummaryPPT
-
Apr 2023Transcript PPT
-
Feb 2023TranscriptPPT
-
Oct 2022TranscriptPPT
-
Jul 2022TranscriptPPT
-
May 2022TranscriptPPT
-
Aug 2021TranscriptPPT
-
May 2021TranscriptPPT
-
Feb 2021TranscriptPPT
-
Nov 2020TranscriptPPT
-
Aug 2020TranscriptPPT
-
May 2020TranscriptPPT
-
Feb 2020TranscriptPPT
-
Nov 2019TranscriptPPT
-
Aug 2019TranscriptPPT
-
May 2019Transcript PPT
-
Feb 2019TranscriptPPT
-
Nov 2018TranscriptPPT
-
Aug 2018TranscriptPPT
-
May 2018Transcript PPT
-
Feb 2018Transcript PPT
-
Nov 2017Transcript PPT
-
Aug 2017TranscriptPPT
-
May 2017TranscriptPPT
-
Feb 2017TranscriptPPT
-
Nov 2016TranscriptPPT
-
Aug 2016Transcript PPT
Market Share
It is a leader in the cybersecurity enterprise solutions space in India, with over 30% market share. [1] In FY24, the company became the only Indian cybersecurity firm listed as a U.S. Artificial Intelligence Safety Institute Consortium Member. [2]